In 1984, Dr. Michael DeBakey and Dr. George Noon performed heart transplant surgery on NASA-Johnson Space Center (JSC) Engineer David Saucier, following a severe heart attack. Six months later, Saucier returned to JSC with the desire to apply spacecraft technology to help people with diseased hearts. As early as 1987, informal meetings began with NASA engineers and Drs. DeBakey and Noon to discuss the design of a low-cost, low-power, implantable ventricular assist device (VAD). Dr. DeBakey instructed the engineers to design a pump that can drain a swimming pool full of water balloons without breaking a single one.In 1996, MicroMed Cardiovascular, Inc. received an exclusive license from NASA to use this rotary blood pump for cardiovascular applications. MicroMed then began the development of the critical support systems that would allow the device (system) to be approved by regulatory agencies and to be utilized in lifesaving applications in humans. European clinical trials of the DeBakey VAD began in November 1998 and CE Mark Certification was awarded in April 2001 for both the Adult and Pediatric VADs. The DeBakey VAD Child received FDA approval in February 2004.